Rapamune (sirolimus) Oral Solution and Tablets
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
November 2015
WARNINGS AND PRECAUTIONS
Interstitial Lung Disease/Non-Infectious Pneumonitis
In some cases, the ILD was reported...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts